Angelini Pharma S.p.a.

Angelini Pharma of Italy, which is hoping to become the leading brain health drugmaker in the sector, is buying a stake in GRIN Therapeutics and securing the international rights to the US biotech’s n

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Quiver, QurAlis To Combine Tech Platfor

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Angelini Licenses Cureverse’s Nov

Angelini SPA has unveiled initial plans to grow its ThermaCare brand after closing its acquisition of the global rights, excluding North America, to the OTC pain-relief line from GSK Consumer Health